Kardia
By AliveCor
Kardia is a medical-grade EKG monitoring app for iOS and Android that pairs with proprietary hardware to detect arrhythmias.
The App DNA
What makes this app unique?
Users report: The app removes the friction of in-office EKG testing by allowing users to record and share clinical-quality heart data from home.
For Patients with diagnosed or suspected arrhythmias requiring remote, medical-grade heart monitoring and their healthcare providers.
What does it look like?
Key features
Automated detection of arrhythmias in 30 seconds via hardware sensor.
Paid-gate service for professional cardiologist interpretation of EKG recordings.
How much does it cost?
Monetization relies on hardware sales and transactional revenue from professional clinical review services.
Velocity
Intense developmentShow more...
5 versions in history. Development pace: intense.
Who built it?
AliveCor
3 apps tracked · Medical
Kardia Korea
KardiaStation ProfessionalUser Sentiment
What do users think recently?
Review voice lately leans excited. Users appreciate portable heart rhythm monitoring provides actionable data that helps users manage their cardiac conditions effectively and peace of mind increases for users who can perform spot checks during moments of cardiac uncertainty.
How are ratings & reviews evolving?
What users say, by theme
- Portable heart rhythm monitoring provides actionable data that helps users manage their cardiac conditions effectively
- Peace of mind increases for users who can perform spot checks during moments of cardiac uncertainty
- Integration with medical records allows for seamless communication between patients and their healthcare providers
- Electrical interference from household electronics frequently causes failed or aborted EKG recording attempts
49 of 49 recent reviews analyzed · high confidence · Excited overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Kardia
How's the Medical market?
Kardia maintains a stable presence in the Medical category, with a 4.8-star rating on iOS across over 210,000 ratings. The high rating count relative to the niche category suggests strong adoption among patients with chronic cardiac conditions.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Kardia
Where is it heading?
The remote cardiac monitoring market is consolidating around clinical-grade data sharing, where Kardia is well-positioned due to its existing physician-connectivity features. However, the app's growth is constrained by hardware-dependent friction and subscription fatigue, which will likely lead to increased churn if recording reliability is not addressed in the next two quarters.
- Frequent recording failures due to environmental interference erode user trust, which compounds the frustration regarding subscription-gated analysis features.
- High clinical trust among cardiologists ensures that Kardia remains the primary data-collection tool for patients, maintaining a stable moat against generic heart-rate trackers.
The SWOT
- Proprietary hardware-app pairing creates a defensible moat against generic sensor alternatives.
- Medical-grade diagnostic capability establishes category authority with cardiologists.
- In-app guidance on minimizing environmental signal interference could improve recording success rates.
Next best moves
Ship in-app signal-interference guidance because it is the top-requested feature to resolve recording failures → reduce aborted session churn.
+ 1 more prioritized moveThe counter-intuitive read
The reliance on proprietary hardware is Kardia's greatest asset, not a liability…
Read the full takeFeature gaps
Automated sensor-agnostic data ingestion (available in Health Diary by MedM but absent here)
Since the last report: Kardia has refined its market positioning toward specialized arrhythmia monitoring while facing new, material user complaints regarding recording reliability and subscription-based feature gating.
Bottom line
Kardia's clinical-grade accuracy retains a loyal patient base, but the current subscription friction threatens long-term engagement. Addressing the recording reliability would unlock higher daily usage, as the current failure rate directly erodes the value of the proprietary hardware.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated